Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7340010rdf:typepubmed:Citationlld:pubmed
pubmed-article:7340010lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:7340010lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7340010lifeskim:mentionsumls-concept:C0431085lld:lifeskim
pubmed-article:7340010lifeskim:mentionsumls-concept:C0032829lld:lifeskim
pubmed-article:7340010lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:7340010lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:7340010lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:7340010lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:7340010lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:7340010lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:7340010pubmed:issue3lld:pubmed
pubmed-article:7340010pubmed:dateCreated1982-6-14lld:pubmed
pubmed-article:7340010pubmed:abstractTextCultures of the human cell line NHIK 3025 were exposed over an 18-month period to 0.5 mumol/1 potassium dichromate (K2Cr2O7) containing 1 mumol/1 hexavalent chromium. The chronically exposed cells increased their tolerance to K2Cr2O7 in comparison to control populations. The doubling time of the chronically exposed cell populations increased even in the absence of K2Cr2O7, but they did not change their morphology (light level), nor contain as many giant cells as newly exposed control populations. Cells returned to control medium for 6 months after 12-months exposure to K2Cr2O7 showed a gradual but incomplete reversal of these effects. The results are compared with those obtained from cells of non-tumour origin.lld:pubmed
pubmed-article:7340010pubmed:languageenglld:pubmed
pubmed-article:7340010pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7340010pubmed:citationSubsetIMlld:pubmed
pubmed-article:7340010pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7340010pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7340010pubmed:statusMEDLINElld:pubmed
pubmed-article:7340010pubmed:issn0300-483Xlld:pubmed
pubmed-article:7340010pubmed:authorpubmed-author:Eik-NesK BKBlld:pubmed
pubmed-article:7340010pubmed:authorpubmed-author:WhiteL RLRlld:pubmed
pubmed-article:7340010pubmed:authorpubmed-author:JakobsenKKlld:pubmed
pubmed-article:7340010pubmed:issnTypePrintlld:pubmed
pubmed-article:7340010pubmed:volume22lld:pubmed
pubmed-article:7340010pubmed:ownerNLMlld:pubmed
pubmed-article:7340010pubmed:authorsCompleteYlld:pubmed
pubmed-article:7340010pubmed:pagination211-8lld:pubmed
pubmed-article:7340010pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7340010pubmed:meshHeadingpubmed-meshheading:7340010-...lld:pubmed
pubmed-article:7340010pubmed:meshHeadingpubmed-meshheading:7340010-...lld:pubmed
pubmed-article:7340010pubmed:meshHeadingpubmed-meshheading:7340010-...lld:pubmed
pubmed-article:7340010pubmed:meshHeadingpubmed-meshheading:7340010-...lld:pubmed
pubmed-article:7340010pubmed:meshHeadingpubmed-meshheading:7340010-...lld:pubmed
pubmed-article:7340010pubmed:meshHeadingpubmed-meshheading:7340010-...lld:pubmed
pubmed-article:7340010pubmed:meshHeadingpubmed-meshheading:7340010-...lld:pubmed
pubmed-article:7340010pubmed:meshHeadingpubmed-meshheading:7340010-...lld:pubmed
pubmed-article:7340010pubmed:year1981lld:pubmed
pubmed-article:7340010pubmed:articleTitleResponse of a human tumour cell line to chronic potassium dichromate exposure.lld:pubmed
pubmed-article:7340010pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7340010pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed